Storage at −3°C for 24 h alters the immunogenicity of pertussis vaccines

This publication has 33 references indexed in Scilit:

• Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines
  Vaccine, 1999
• Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine
  The Lancet, 1997
• Cold chain in a hot climate
  Australian and New Zealand Journal of Public Health, 1996
• Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T‐cell subsets as Th1, Th2 or Th0
  Immunology, 1996
• Pertussis Infection among Adults during the 1993 Outbreak in Chicago
  The Journal of Infectious Diseases, 1995
• Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany
  Vaccine, 1994
• How common is whooping cough in a nonvaccinating country?
  The Pediatric Infectious Disease Journal, 1993
• Storage of vaccines in the community: weak link in the cold chain?
  BMJ, 1992
• Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants
  The Journal of Pediatrics, 1991
• Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody
  The Journal of Pediatrics, 1990